HAYA Therapeutics
Operator of a precision therapeutics company intended to discover and develop tissue and cell-selective genomic medicines for fibrotic diseases. The company's therapeutics utilize biopharmaceutical th...
Valuation
$115.5M
Latest known
Share Price
N/A
Total Raised
$101M
Last Round
N/A